Paradigm Biocapital Advisors LP - Jun 30, 2025 SCHEDULE 13G/A Report for Janux Therapeutics, Inc. Common Stock, $0.001 par value per share (JANX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Janux Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
JANX
Shares outstanding
59.6M shares
Disclosed Ownership
2.92M shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 04:31 PM
Date of event
Jun 30, 2025
Previous filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 4.9% 2.92M 2.92M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 4.9% 2.92M 2.92M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 4.9% 2.92M 2.92M 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.4% 2.59M 2.59M 0 /s/ David K. Kim David K. Kim / Authorized Signatory